Published peptide research references
Teduglutide
Governed registry record
185 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Open the peptide evidence profile →Approved source records
Add-on to current guidelines for monitoring of SBS patients treated with teduglutide
DOI: 10.1038/s44355-025-00047-7
Source identity and connection checked by Codex (AI).
Comment on "real-world experience of teduglutide for the treatment of short bowel syndrome-associated intestinal failure".
DOI: 10.1016/j.clnesp.2026.105083PMID: 42674361
Source identity and connection checked by Codex (AI).
Effectiveness and Safety of Teduglutide Treatment in Adult Patients with Short Bowel Syndrome: A Case Series and Review of Current Evidence.
DOI: 10.3390/jcm15052033PMID: 41827448
Source identity and connection checked by Codex (AI).
PERCC1-associated enteropathy: Diagnostic challenges and enteral autonomy achieved with teduglutide.
DOI: 10.1002/jpr3.70144PMID: 42110144
Source identity and connection checked by Codex (AI).
Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina.
DOI: 10.4292/wjgpt.v16.i4.110642PMID: 41378076
Source identity and connection checked by Codex (AI).
Real-world effectiveness and safety of teduglutide in patients with short bowel syndrome.
DOI: 10.4292/wjgpt.v17.i1.117071PMID: 41809219
Source identity and connection checked by Codex (AI).
Safety and long-term effectiveness of teduglutide in children with intestinal failure due to short bowel syndrome: a multicenter, post-marketing cohort study.
DOI: 10.1038/s41390-026-05489-0PMID: 42754721
Source identity and connection checked by Codex (AI).
Successful treatment with teduglutide for an adolescent with cerebral palsy accompanied by short bowel syndrome.
DOI: 10.1111/ped.15894PMID: 40019443
Source identity and connection checked by Codex (AI).
Teduglutide in Enterocolitis Secondary to Graft-Versus-Host Disease Post-Bone Transplant: Case Report
DOI: 10.20944/preprints202602.1566.v1
Source identity and connection checked by Codex (AI).
Development of Teduglutide purity certified reference material (GBW09342) through amino acid-based isotope dilution mass spectrometry and sulfur-based isotope dilution inductively coupled plasma mass spectrometry.
2027
A case report on the long-term use of teduglutide in a pediatric patient with short bowel syndrome.
2026
Assessing the health-related quality of life and clinical effect in children with short bowel syndrome receiving teduglutide treatment.
2026
Association between teduglutide treatment and long-term reductions in parenteral support: An observational cohort study of adults with short bowel syndrome.
2026
Clinical outcomes of teduglutide therapy in children with short bowel syndrome-associated intestinal failure: A single-center experience.
2026
Development of a consensus parenteral solution weaning algorithm for children with short-bowel syndrome associated intestinal failure responding to teduglutide therapy.
2026
Efficacy and safety of teduglutide in children with short bowel syndrome: a narrative review.
2026
Growth trajectories of children with short bowel syndrome during the first year of teduglutide treatment.
2026
Optimizing teduglutide treatment regimens in children with short bowel syndrome.
2026
Outcomes and adverse effects of teduglutide treatment with periodic withdrawal in pediatric short bowel patients.
2026
Quality of life for pediatric patients with short bowel syndrome-associated intestinal failure treated with teduglutide.
2026
Real-world experience of teduglutide for the treatment of short bowel syndrome-associated intestinal failure.
2026
Six-Month Safety and Effectiveness of Teduglutide in Patients with Short Bowel Syndrome in Japan: Interim Analysis of Post-marketing Surveillance.
2026
Successful treatment with teduglutide in short bowel syndrome with intestinal failure secondary to small-bowel volvulus: a case report and literature review.
2026
Teduglutide in pediatric patients under 10 kg with short bowel syndrome on parenteral support: An open-label study.
2026
Teduglutide use in haemodialysis-dependent renal failure from secondary hyperoxaluria in short bowel syndrome and type 3 intestinal failure - A case report.
2026
[Use of teduglutide in short bowel syndrome in infants, children and adolescents: Position paper of the working group "Chronic intestinal failure" of the Society for Paediatric Gastroenterology and Nutrition (GPGE)].
2026
Efficacy of Teduglutide in Pediatric Short Bowel Syndrome: Association with Citrulline Levels and Anatomical Location of Remnant Small Intestine.
2025
Encapsulation of hydrophobically ion-paired teduglutide in nanoemulsions: Effect of anionic counterions.
2025
Forty-eight months outcomes of teduglutide treatment in adult stable patients with short bowel syndrome and home parenteral nutrition dependence: A real-world Italian single-center observational cohort study.
2025
Identification of Pappalysin-2 (PAPP-A2), a modulator of Insulin-like Growth Factor-1 pathway, as a potential marker of teduglutide efficacy in patients with short bowel syndrome.
2025
Impact of teduglutide on pediatric short bowel syndrome: A systematic review and trial sequential meta-analysis.
2025
Quality of life and lived experience of patients with short bowel syndrome treated with teduglutide and weaning off home parenteral nutrition: a qualitative analysis of patient diaries.
2025
Real-world experience of Teduglutide use in adults with short bowel syndrome: A seven-year international multicenter survey.
2025
Reduction of Parenteral Nutrition in Children with Short Bowel Syndrome Treated with Teduglutide: Experience from the Czech Republic.
2025
Safety of Teduglutide for Managing Patients with Short Bowel Syndrome: A Systematic Review and Meta-analysis.
2025
Short bowel syndrome and d-lactic acidosis: A case report with supplemental home parenteral nutrition and teduglutide.
2025
Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey.
2025
Teduglutide in adults with short bowel syndrome and intestinal failure: A descriptive cohort study.
2025
Baseline Characteristics of Adult Patients Treated and Never Treated with Teduglutide in a Multinational Short Bowel Syndrome and Intestinal Failure Registry.
2024
Cost-Effectiveness of Teduglutide for Pediatric Patients with Short Bowel Syndrome in Japan, Including Caregiver Burden.
2024
Cost-effectiveness of teduglutide in adult patients with short bowel syndrome - a European socioeconomic perspective.
2024
Early use of teduglutide in paediatric patients with intestinal failure is associated with a greater response rate: a multicenter study.
2024
Effect of teduglutide, a glucagon-like peptide-2 analog, in eosinophilic enterocolitis: a case report.
2024
Long-term outcomes and adverse effects of teduglutide in patients with short bowel syndrome: Highlighting hyperamylasemia and hyperlipasemia.
2024
Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure.
2024
Management Patterns of Teduglutide Use in Short Bowel Syndrome: A Survey of 70 Healthcare Professionals.
2024
Orally Delivered Stimulus-Sensitive Nanomedicine to Harness Teduglutide Efficacy in Inflammatory Bowel Disease.
2024
Reversal of Intestinal Failure With Teduglutide in <i>PERCC1</i>-Associated Enteropathy: A Case Report.
2024
Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis.
2024
The Impact of Teduglutide on Real-Life Health Care Costs in Children with Short Bowel Syndrome.
2024
Use of Teduglutide in the Management of Gastrointestinal Graft-versus-Host Disease in Children and Young Adults.
2024
Use of teduglutide in adults with short bowel syndrome-associated intestinal failure.
2024
Adult patients with short bowel syndrome treated with teduglutide: A descriptive cohort study.
2023
Case report: Exploring teduglutide as a therapeutic option for refractory microscopic colitis: insights and implications.
2023
Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing.
2023
Cost-utility analysis of teduglutide compared to standard care in weaning parenteral nutrition support in children with short bowel syndrome.
2023
Effects of Teduglutide on Diarrhea in Pediatric Patients with Short Bowel Syndrome-Associated Intestinal Failure.
2023
Efficacy and Safety of Teduglutide in Infants and Children With Short Bowel Syndrome Dependent on Parenteral Support.
2023
Efficacy, safety, and pharmacokinetics of teduglutide in adult Japanese patients with short bowel syndrome and intestinal failure: two phase III studies with an extension.
2023
Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome.
2023
Nutritional management of a patient with chronic intestinal failure and hemodialysis receiving teduglutide: A case report.
2023
Post-Marketing Use of Teduglutide in a Large Cohort of Adults with Short Bowel Syndrome-Associated Chronic Intestinal Failure: Evolution and Outcomes.
2023
Predictive Potential of Biomarkers of Intestinal Barrier Function for Therapeutic Management with Teduglutide in Patients with Short Bowel Syndrome.
2023
Quality of Life in Teduglutide-Treated Patients with Short Bowel Syndrome Intestinal Failure-A Nested Matched Pair Real-World Study.
2023
Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure.
2023
Teduglutide for the treatment of short bowel syndrome: a double-edged sword?
2023
The indications and results of the use of teduglutide in patients with short bowel.
2023
Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring.
2023
Use of teduglutide for short bowel syndrome and Crohn's disease in a patient treated with ustekinumab and vedolizumab dual biologic therapy.
2023
[Expert recommendations on the use of teduglutide in pediatric patients with short bowel syndrome].
2023
[Review of real-life teduglutide experience].
2023
Changes in Parenteral Nutrition Requirements and BMI in Patients with Parenteral Nutrition-Dependent Short Bowel Syndrome after Stopping Teduglutide-9 Years of Follow-Up.
2022
Characterization of American teduglutide consumers from 2015 to 2020: A large database study.
2022
Efficacy of Teduglutide for Parenteral Support Reduction in Patients with Short Bowel Syndrome: A Systematic Review and Meta-Analysis.
2022
Hernia enlargement and pancreatitis in a patient with short bowel syndrome treated with teduglutide.
2022
Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program.
2022
Method for identification and quantification of intact teduglutide peptide using (RP)UHPLC-UV-(HESI/ORBITRAP)MS.
2022
Teduglutide for the treatment of low-output enterocutaneous fistula - A pilot randomized controlled study.
2022
Teduglutide in pediatric intestinal failure: A position statement of the Italian society of pediatric gastroenterology, hepatology and nutrition (SIGENP).
2022
Teduglutide in short bowel syndrome patients: A way back to normal life?
2022
The Variable Response to Teduglutide in Pediatric Short Bowel Syndrome: A Single Country Real-Life Experience.
2022
Tracking the physicochemical stability of teduglutide (Revestive®) clinical solutions over time in different storage containers.
2022
Use of Teduglutide in Children With Intestinal Failure: A Systematic Review.
2022
Cost-effectiveness of teduglutide in pediatric patients with short bowel syndrome: Markov modeling using traditional cost-effectiveness criteria.
2021
De Novo Development of Distal Jejunal and Duodenal Adenomas After 41 Months of Teduglutide Treatment in a Patient With Short-Bowel Syndrome: A Case Report.
2021
Designing Novel Teduglutide Analogues with Improved Binding Affinity: An In Silico Peptide Engineering Approach.
2021
Expression, purification and molecular dynamics simulation of extracellular domain of glucagon-like peptide-2 receptor linked to teduglutide.
2021
Imaging as predictor of clinical response to teduglutide in adult patients with short bowel syndrome with chronic intestinal failure.
2021
Intestinal iatrogenic hyperadaptation in patients with short bowel syndrome and Crohn's disease: Is this an indication for mandatory lifelong injections of teduglutide?
2021
Long-Term Outcomes With Teduglutide From a Single Center.
2021
Long-term Effects of Teduglutide on Intestinal Mucosa in a Patient With Crohn's Disease and Short Bowel Syndrome: Clinical, Endoscopic and Histological Data Compared.
2021
Population pharmacokinetics and exposure-response analyses of teduglutide in adult and pediatric patients with short bowel syndrome.
2021
Predictors and timing of response to teduglutide in patients with short bowel syndrome dependent on parenteral support.
2021
Safety Findings in Pediatric Patients During Long-Term Treatment With Teduglutide for Short-Bowel Syndrome-Associated Intestinal Failure: Pooled Analysis of 4 Clinical Studies.
2021
Teduglutide Therapy in 2 Patients With Short-Bowel Syndrome and Familial Adenomatous Polyposis.
2021
Teduglutide for pediatric short bowel syndrome patients.
2021
Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
2020
Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series.
2020
Comprehensive nutritional assessment in short bowel syndrome with chronic renal failure on teduglutide therapy: A case report.
2020
Cost-effectiveness of teduglutide in adult patients with short bowel syndrome: Markov modeling using traditional cost-effectiveness criteria.
2020
Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials.
2020
Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data.
2020
GLP-2 analog Teduglutide in active Crohn's disease and short bowel syndrome: Confirmation of anti-inflammatory role and future perspectives.
2020
Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
2020
Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III Study.
2020
Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study.
2020
Small-Bowel Adaptation: A Case of Morphological Changes Induced by Teduglutide in Short-Bowel Syndrome With Intestinal Failure.
2020
Teduglutide Promotes Epithelial Tight Junction Pore Function in Murine Short Bowel Syndrome to Alleviate Intestinal Insufficiency.
2020
Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials.
2020
The Glucagon-Like Peptide 2 Analog Teduglutide Reversibly Associates to Form Pentamers.
2020
Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short-Bowel Syndrome: A Review of Recent Literature.
2020
[Is there life after teduglutide?]
2020
Accelerated Colorectal Polyposis in an Immunosuppressed Patient With a Small Bowel Transplant Treated With Teduglutide: Case Report and Review of Literature.
2019
Effect of teduglutide on restoring oral autonomy for magnesium in two patients with short bowel.
2019
Experience with teduglutide treatment for short bowel syndrome in clinical practice.
2019
Off-Label Teduglutide Therapy in Non-intestinal Failure Patients with Chronic Malabsorption.
2019
Teduglutide in Patients With Active Crohn's Disease and Short Bowel Syndrome.
2019
De Novo Development of Hamartomatous Duodenal Polyps in a Patient With Short Bowel Syndrome During Teduglutide Therapy: A Case Report.
2018
Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
2018
Further improvement after 24-month treatment with teduglutide in a patient with active Crohn's disease and short bowel syndrome.
2018
GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting.
2018
Intestinal Epithelial Stem Cells: Distinct Behavior After Surgical Injury and Teduglutide Administration.
2018
Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series.
2018
Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
2018
Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome.
2018
Teduglutide for the treatment of short bowel syndrome - a safety evaluation.
2018
Teduglutide-induced stem cell function in intestinal repair.
2018
Tissular growth factors profile after teduglutide administration on an animal model of intestinal anastomosis.
2018
Enteral Autonomy with Teduglutide Treatment of Intestinal Failure/Short Bowel Syndrome with Depleted Central Venous Access.
2017
Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
2017
Intestinal inflammatory and redox responses to the perioperative administration of teduglutide in rats.
2017
Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome.
2017
Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of Teduglutide.
2017
Results of 12-month rescue treatment with Teduglutide in severely active and parenteral nutrition-dependent Crohn's disease.
2017
Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
2017
Teduglutide effects on gene regulation of fibrogenesis on an animal model of intestinal anastomosis.
2017
Teduglutide for treatment of adult patients with short bowel syndrome.
2017
Teduglutide-Stimulated Intestinal Adaptation Is Complemented and Synergistically Enhanced by Partial Enteral Nutrition in a Neonatal Piglet Model of Short Bowel Syndrome.
2017
Teduglutide: A Review in Short Bowel Syndrome.
2017
The Polish Intestinal Failure Centres' consensus on the use of teduglutide for the treatment of short bowel syndrome.
2017
A Patient With Parenteral Nutrition-Dependent Short Bowel Syndrome and Cardiovascular Disease With 4-Year Exposure to Teduglutide.
2016
Acute Effects of a Glucagon-Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition.
2016
Clinical Management of Patients With Parenteral Nutrition-Dependent Short Bowel Syndrome During Teduglutide Therapy.
2016
Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome.
2016
Response to "Teduglutide and Intestinal Permeability in Short Bowel Syndrome".
2016
Teduglutide and Intestinal Permeability in Short Bowel Syndrome.
2016
Teduglutide for Safe Reduction of Parenteral Nutrient and/or Fluid Requirements in Adults: A Systematic Review.
2016
Effect of Teduglutide, a Glucagon-like Peptide 2 Analog, on Citrulline Levels in Patients With Short Bowel Syndrome in Two Phase III Randomized Trials.
2015
Teduglutide: a guide to its use in short bowel syndrome.
2015
[Statement of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) for teduglutide-benefit assessment according to § 35a SGB V the G-BA].
2015
A randomized, double-blind, placebo-controlled, multiple-dose, parallel-group clinical trial to assess the effects of teduglutide on gastric emptying of liquids in healthy subjects.
2014
Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome.
2014
Teduglutide for the Treatment of Short Bowel Syndrome.
2014
Utility of a population pharmacokinetic meta analysis during the approval process of teduglutide for the treatment of short bowel syndrome.
2014
Vortioxetine hydrobromide, crofelemer, and teduglutide.
2014
Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells.
2013
Increased intestinal absorption in the era of teduglutide and its impact on management strategies in patients with short bowel syndrome-associated intestinal failure.
2013
Pharmacokinetics of teduglutide in subjects with renal impairment.
2013
Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
2013
Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure.
2013
Study of teduglutide effectiveness in parenteral nutrition-dependent short-bowel syndrome subjects.
2013
Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome.
2013
Teduglutide for the treatment of short bowel syndrome.
2013
Teduglutide injection (Gattex) for short bowel syndrome.
2013
Teduglutide: a review of its use in the treatment of patients with short bowel syndrome.
2013
The long road to a new short-bowel therapy: teduglutide for clinical use.
2013
[Short bowel syndrome. GLP-2 analog teduglutide].
2013
A Thorough QT Study of Teduglutide in Healthy Subjects.
2012
Teduglutide and short bowel syndrome: every night without parenteral fluids is a good night.
2012
Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
2012
Teduglutide, a glucagon-like peptide 2 analogue: a novel protective agent with anti-apoptotic and anti-oxidant properties in mice with lung injury.
2012
Treatment of adult short bowel syndrome patients with teduglutide.
2012
Effect of different doses of GLP-2 (Teduglutide) on acute esophageal lesion due to acid-pepsin perfusion in male rats.
2011
Maintenance of parenteral nutrition volume reduction, without weight loss, after stopping teduglutide in a subset of patients with short bowel syndrome.
2011
Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.
2011
Population pharmacokinetics of teduglutide following repeated subcutaneous administrations in healthy participants and in patients with short bowel syndrome and Crohn's disease.
2010
Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.
2010
Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease.
2010
Clinical trial simulations in pediatric patients using realistic covariates: application to teduglutide, a glucagon-like peptide-2 analog in neonates and infants with short-bowel syndrome.
2009
Pharmacokinetics, safety, and tolerability of teduglutide, a glucagon-like peptide-2 (GLP-2) analog, following multiple ascending subcutaneous administrations in healthy subjects.
2008
Teduglutide in intestinal adaptation and repair: light at the end of the tunnel.
2008
Teduglutide
2006
Teduglutide for the treatment of short bowel syndrome.
2006
Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
2005
Teduglutide ([Gly2]GLP-2) protects small intestinal stem cells from radiation damage.
2004